Precigen PGEN
NASDAQ PGEN
$7.18 +0.04 (+0.49%)
As of: Sep 4, 2026 · 3:22 PM EDT

Precigen (PGEN) Profit After Tax (2012 - 2026)

Precigen (PGEN) posted quarterly Profit After Tax of -$7.9 million for Q1 2026, up 85.36% year-over-year from -$4.3 million in Q1 2025, and up 66.26% quarter-over-quarter from -$23.5 million in Q4 2025.

Analysis

Precigen (PGEN) Profit After Tax (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Profit After Tax for 15 consecutive years, with -$7.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax rose 85.36% year-over-year to -$7.9 million; the TTM figure through Mar 2026 stood at -$204.4 million (down 30.49% YoY), while the FY2025 annual figure was -$250.6 million, down 98.55% from the prior year.
  • Profit After Tax rose to -$7.9 million in Q1 2026 per PGEN's latest filing, from -$23.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $87.4 million in Q3 2022 and bottomed at -$146.3 million in Q3 2025.
  • Historically, Profit After Tax has averaged -$26.6 million across 5 years, with a median of -$22.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Profit After Tax surged 393.57% — and 2025, when it plunged 510.33%.
  • Precigen's Profit After Tax stood at -$22.2 million in 2022, then sank by 49.06% to -$33.1 million in 2023, then soared by 40.32% to -$19.7 million in 2024, then dropped by 19.14% to -$23.5 million in 2025, then jumped by 66.26% to -$7.9 million in 2026.
  • Business Quant data shows PGEN's Profit After Tax at -$7.9 million in Q1 2026, -$23.5 million in Q4 2025, and -$146.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -644.37 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 81.49 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -16.62 Mn
10 Precigen 2.56 Bn 2.56 Bn 52.17 Mn 20.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.07 Mn
Mar 31, 2026 -7.93 Mn
Dec 31, 2025 -23.50 Mn
Sep 30, 2025 -146.34 Mn
Jun 30, 2025 -26.64 Mn
Mar 31, 2025 -54.15 Mn
Dec 31, 2024 -19.73 Mn
Sep 30, 2024 -23.98 Mn
Jun 30, 2024 -58.79 Mn
Mar 31, 2024 -23.74 Mn
Dec 31, 2023 -33.06 Mn
Sep 30, 2023 -19.80 Mn
Jun 30, 2023 -20.32 Mn
Mar 31, 2023 -22.73 Mn
Dec 31, 2022 -22.18 Mn
Sep 30, 2022 87.38 Mn
Jun 30, 2022 -17.64 Mn
Mar 31, 2022 -19.25 Mn
Dec 31, 2021 -25.03 Mn
Sep 30, 2021 -29.76 Mn